RECRUITING

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy

Official Title

Phase III Randomized Clinical Trial for Stage III Epithelial Ovarian Cancer Randomizing Between Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy

Quick Facts

Study Start:2020-01-01
Study Completion:2026-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03772028

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * candidate for primary CRS
  2. * histological or cytological proven FIGO stage III primary epithelial ovarian, fallopian tube, or extra-ovarian cancer
  1. * history of previous malignancies within 5 years prior to inclusion
  2. * FIGO stage IV disease
  3. * complete primary cytoreduction is impossible
  4. * prior treatment for the current malignancy

Contacts and Locations

Study Contact

Willemien van Driel, MD, PhD
CONTACT
031 20 512 7918
OVHIPEC@nki.nl
Lot Aronson
CONTACT
031 20 512 7918
OVHIPEC@nki.nl

Study Locations (Sites)

City of Hope
Duarte, California, 91010
United States
MSKCC New York
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: The Netherlands Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-01
Study Completion Date2026-04-01

Study Record Updates

Study Start Date2020-01-01
Study Completion Date2026-04-01

Terms related to this study

Keywords Provided by Researchers

  • ovarian cancer
  • HIPEC
  • OVHIPEC
  • primary debulking

Additional Relevant MeSH Terms

  • Ovarian Cancer